High single-dose efficacy of Pfizer vaccine against SARS-CoV-2 in older adults


Sumary of High single-dose efficacy of Pfizer vaccine against SARS-CoV-2 in older adults:

  • In British Columbia (BC), Canada, vaccination against coronavirus disease 2019 (COVID-19) began with the Pfizer/Moderna mRNA (messenger ribonucleic acid) vaccines began with nursing home residents and frontline healthcare workers..
  • New research by scientists in Canada suggests that these are known to have a high protective efficacy of 92-93% after a single dose, but this data comes from younger and healthy adults, for the most part..
  • Background Since vaccine stocks are in short supply, many countries resorted to lengthening the interval between doses to increase single-dose coverage, thus protecting more people in a shorter time..
  • This has made it difficult to differentiate direct and indirect vaccine effects, as well as the effect of the first dose as compared to that of both doses..
  • Those who had positive virus tests by reverse transcriptase-polymerase chain reaction (RT-PCR) on specimens between weeks 14-17 from the start of the pandemic in BC were included..
  • Community testing based on symptoms was used to identify real-life vaccine efficacy against all variants, including VOCs, after one dose of an mRNA vaccine..
  • Related Stories Vaccine coverage (prime dose) among both cases and controls reached 85% and 90%, by week 14, 85% with the Pfizer vaccine..
  • Vaccination associated with 65% fall in cases The findings show that vaccine efficacy (VE) was insignificant until two weeks after vaccination, increasing over the next week to 43% at 14-20 days….

Want to know more click here go to source.

From -
Generic selectors
Exact matches only
Search in title
Search in content

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.